Stock Track | Syndax Pharmaceuticals Plummets 5.20% Intraday Amid Conflicting Analyst Sentiments

Stock Track
01/13

Syndax Pharmaceuticals (SNDX) saw its stock price drop sharply by 5.20% during Tuesday's intraday trading session. The decline comes as analysts expressed conflicting sentiments about the company's prospects in a recent report.

The healthcare sector has been under scrutiny, with analysts weighing in on various companies, including Syndax Pharmaceuticals. The mixed opinions from analysts may have contributed to investor uncertainty, leading to the significant sell-off observed in SNDX shares.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10